Benzenoids
Medchemexpress LLC Bempedoic acid | 738606-46-7 | MFCD18800820 | 98.0% | 344.49 g·mol⁻¹ | C19H36O5 | 10MM 1ML
Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor used in biochemical and cellular research to modulate lipid metabolism and activate AMPK. The material is supplied as a powder and is commonly prepared as concentrated stocks in DMSO (for example, 10 mM). Intended for research use only.
- ATP-citrate lyase inhibitor and AMPK activator.
- Supplied as powder suitable for preparation of DMSO stock solutions.
- Molecular formula C19H36O5; molecular weight 344.49 g·mol⁻¹.
- Typical purity 98.0% (NMR) as reported on certificate of analysis.
- Recommended storage: powder -20 °C for long term; in solvent -80 °C.
Cell Signaling Technology Complement C3 (E4D2Z) Rabbit mAb 20 ul
Complement C3 (E4D2Z) Rabbit mAb 20 ul
Cell Signaling Technology TACSTD2/TROP2 (F4W4J) Rabbit mAb 20 ul
TACSTD2/TROP2 (F4W4J) Rabbit mAb 20 ul
Medchemexpress LLC 20-hydroxyeicosanoic acid | 62643-46-3 | MFCD02259050 | 98.0% | 328.54 g/mol | C20H40O3 | 10G
20-Hydroxyeicosanoic acid is a hydroxylated long-chain (C20) fatty acid supplied as a high-purity research reagent for biochemical and analytical applications. It is suitable as a reference standard for metabolic studies and for analytical method development.
- High purity 98.0%
- Molecular formula C20H40O3; molecular weight 328.54 g/mol
- Available in 10 g packaging
- Storage: room temperature (3 years); in solvent: -80°C (2 years), -20°C (1 year)
- Intended for research and analytical use; not for human or clinical use
Apexbio Technology LLC Glimepiride 93479-97-1 5g
Glimepiride (CAS 93479-97-1) is a sulfonylurea compound widely used in research on type 2 diabetes It primarily acts by enhancing glucose uptake both in the presence and absence of insulin In cultured cells glimepiride (10 M) increases 2-deoxyglucose uptake to 186% of control and upregulates GLUT1 and GLUT4 expression to 164% and 148% of control respectively indicating insulin-independent mechanisms for stimulating cardiac glucose uptake In rodent models glimepiride administration reduced diabetes incidence by 23% in BB rats and decreased blood glucose HbA1c and plasma insulin levels in KK-Ay mice highlighting its utility for investigating glucose metabolism and diabetes pathophysiology
Accela Chembio Inc 4-bromo-2-fluorophenylacetic Acid | 1g | 114897-92-6 | MFCD09032952 | 97+% | Shelf Life: 1260 Days | Light Sensitive
4-bromo-2-fluorophenylacetic Acid | 1g | 114897-92-6 | MFCD09032952 | 97+% | Shelf Life: 1260 Days | Light Sensitive
Medchemexpress LLC 2-Oxa-5-azabicyclo[2.2.1]heptane, 5-[2-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-6-[6-(4-methoxy-3-pyridinyl)-4-methyl-1H-pyrazolo[4,3-c]pyridin-1-yl]-1-methyl-1H-imidazo[4,5-c]pyridin-4-yl]-, (1R,4R)- | 2769715-68-4 | 99.3% | 592.69 | 5 MG
2-Oxa-5-azabicyclo[2.2.1]heptane, 5-[2-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-6-[6-(4-methoxy-3-pyridinyl)-4-methyl-1H-pyrazolo[4,3-c]pyridin-1-yl]-1-methyl-1H-imidazo[4,5-c]pyridin-4-yl]-, (1R,4R)- | 2769715-68-4 | 99.3% | 592.69 | 5 MG
Medchemexpress LLC Pat1inh-b01 hydrochloride | C22H19BrClF3N6O2 | 5 MG
PAT1inh-B01 hydrochloride is a selective SLC26A6 inhibitor that blocks fluid absorption in the small intestine. It can be used for research into small intestinal hyposecretory disorders. For research use only, not for sale to patients.
- Inhibits PAT1 (a Cl-/HCO3- exchanger)-mediated anion exchange with an IC50 of 350 nM
- Blocks fluid absorption in the small intestine
- Suitable for research of small intestinal hyposecretory disorders
Cayman Chemical Bergamottin Natural Products E
A naturally occurring furanocoumarin; inhibits migration and invasion of HT-1080 fibrosarcoma cells at sub-cytotoxic concentrations via inhibition of MMP-9 expression; shows antiproliferative activity against HepG2 liver, HL-60 leukemia, and BGC-823 gastric cancer cell lines in a dose-dependent manner; induces cell death of CHO cells following near ultraviolet irradiation; inhibits CYP3A4 (Ki = 7.7 μM); a mixed inhibitor of simvastatin drug metabolism (Ki = 174 μM); increases glucose consumption in HepG2 cells in a dose-dependent manner
eMolecules Broadpharm / Pyrene azide 2 / 1mg / 296213707 / BP-22549 / 96.000 / 1807512-45-3 / MFCD28385514 / 416.481 / C24H24N4O3
Broadpharm / Pyrene azide 2 / 1mg / 296213707 / BP-22549 / 96.000 / 1807512-45-3 / MFCD28385514 / 416.481 / C24H24N4O3
Medchemexpress LLC SBI-810 (hydrochloride) | 2772746-58-2 | 99.6% | 483.05 | 1 ML
SBI-810 hydrochloride is a functionally selected β-arrestin-biased neurotensin receptor 1 (NTSR1) allosteric modulator. It modulates NTSR1 G protein signaling in a G protein-specific manner in the presence of the endogenous ligand, neurotensin (NT). This compound fully antagonizes NT-induced activation of Gq, partially antagonizes NT-induced activation of Gi1, and is permissive of NTSR1 activation of GoA and G12.
- Functionally selected β-arrestin-biased neurotensin receptor 1 (NTSR1) allosteric modulator.
- Modulates NTSR1 G protein signaling in a G protein-specific manner with neurotensin (NT).
- Fully antagonizes NT-induced activation of Gq.
- Partially antagonizes NT-induced activation of Gi1.
- Permissive of NTSR1 activation of GoA and G12.
- For research use only.
Medchemexpress LLC 4-pyrimidinamine, 6-chloro-N-(phenylmethyl)- | 61667-16-1 | MFCD00679879 | 99.7% | 219.67 g/mol | C11H10ClN3 | 50 MG
N-Benzyl-6-chloropyrimidin-4-amine is a pyrimidine-derived research compound used as a building block in medicinal chemistry and biochemical screening. It is supplied as a solid or as a DMSO solution and features a chlorinated pyrimidine core.
- High reported purity suitable for research use.
- Available in small sample and mg-scale quantities.
- Off-white solid appearance for easy handling.
- Provided as a 10 mM solution in DMSO for screening workflows.
- Suitable as a synthetic intermediate or screening reagent.
- Certificate of analysis available for batch traceability.
Selleck Chemical LLC 4-Hydroxy-3-methylbenzoic acid
4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population